The FDA's push for lower-cost medicines looks good on paper, but the patent office under President Trump may be going in the ...
Oregon Health & Science University leaders say a federal drug discount pilot set to begin next year could create a ...
What Happened: Khosla's recent move involves selling 890 shares of Amgen. This information is documented in a Form 4 filing ...
With immunology and inflammation blockbusters like AbbVie’s Skyrizi and Rinvoq reeling in nearly $7 billion combined in the ...
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range ...
Dear reader, when we discuss the best-selling medications of all time, we’re exploring more than just products with massive ...
AgeOptions, the Area Agency on Aging for suburban Cook County, and Pathlights offer help navigating Medicare open enrollment ...
Inside Providence plan 340B rebate disruption details the system’s financial and operational readiness for the new federal rebate pilot program.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback